Localized viral vector delivery to enhance in situ regenerative gene therapy

Gene Therapy

Volumn 14, Issue 11, 2007, Pages 891-901

  Hu, W W ^a   Wang, Z ^a   Hollister, S J ^a,b   Krebsbach, Paul H ^a  

^a UNIVERSITY OF MICHIGAN   (United States)

^b UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOVIRUS VECTOR; BETA GALACTOSIDASE; BIOMATERIAL; BONE MORPHOGENETIC PROTEIN 2; GELATIN SPONGE; HYDROXYAPATITE; PHOSPHATE BUFFERED SALINE; SUCROSE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BONE REGENERATION; COMPUTER ASSISTED TOMOGRAPHY; CONTROLLED STUDY; FIBROBLAST CULTURE; FREEZE DRYING; GENE EXPRESSION; GENETIC TRANSDUCTION; HUMAN; HUMAN CELL; IN VIVO STUDY; INTERMETHOD COMPARISON; NONHUMAN; OSSIFICATION; PRIORITY JOURNAL; RAT; REPORTER GENE; SKULL DEFECT; STORAGE TEMPERATURE; TEMPERATURE DEPENDENCE; VIRAL GENE DELIVERY SYSTEM; VIRAL GENE THERAPY;

ADENOVIRIDAE; ADENOVIRIDAE INFECTIONS; ANIMALS; BETA-GALACTOSIDASE; BIOCOMPATIBLE MATERIALS; BONE AND BONES; BONE MORPHOGENETIC PROTEINS; BONE REGENERATION; DURAPATITE; FRACTURES, BONE; FREEZE DRYING; GELATIN SPONGE, ABSORBABLE; GENE EXPRESSION; GENE THERAPY; GENETIC ENGINEERING; GENETIC VECTORS; IMPLANTS, EXPERIMENTAL; INJECTIONS; RATS; RATS, INBRED F344; TOMOGRAPHY, X-RAY COMPUTED; TRANSDUCTION, GENETIC; TRANSFORMING GROWTH FACTOR BETA;

ADENOVIRIDAE; RATTUS;

EID: 34249106200     PISSN: 09697128     EISSN: 14765462     Source Type: Journal    
DOI: 10.1038/sj.gt.3302940     Document Type: Article

References (44)

1. Lutolf MP, Weber FE, Schmoekel HG, Schense JC, Kohler T, Muller R et al. Repair of bone defects using synthetic mimetics of collagenous extracellular matrices. Nat Biotechnol 2003; 21: 513-518.
2. Sheridan MH, Shea LD, Peters MC, Mooney DJ. Bioabsorbable polymer scaffolds for tissue engineering capable of sustained growth factor delivery. J Control Release 2000; 64: 91-102.
3. Tabata Y. Tissue regeneration based on growth factor release. Tissue Eng 2003; 9 (Suppl): S5-S15.
4. Boyne PJ, Marx RE, Nevins M, Triplett G, Lazaro E, Lilly LC et al. A feasibility study evaluating rhBMP-2/absorbable collagen sponge for maxillary sinus floor augmentation. Int J Periodontics Restorative Dent 1997; 17: 11-25.
5. Howell TH, Fiorellini J, Jones A, Alder M, Nummikoski P, Lazaro M et al. A feasibility study evaluating rhBMP-2/absorbable collagen sponge device for local alveolar ridge preservation or augmentation. Int J Periodontics Restorative Dent 1997; 17: 124-139.
6. Fang J, Zhu YY, Smiley E, Bonadio J, Rouleau JP, Goldstein SA et al. Stimulation of new bone formation by direct transfer of osteogenic plasmid genes. Proc Natl Acad Sci USA 1996; 93: 5753-5758.
7. Hannallah D, Peterson B, Lieberman JR, Fu FH, Huard J. Gene therapy in orthopaedic surgery. J Bone Joint Surg - Am Vol 2002; 84A: 1046-1061.
8. Franceschi RT. Biological approaches to bone regeneration by gene therapy. J Dent Res 2005; 84: 1093-1103.
9. Selkirk SM. Gene therapy in clinical medicine. Postgrad Med J 2004; 80: 560-570.
10. Ito H, Koefoed M, Tiyapatanaputi P, Gromov K, Goater JJ, Carmouche J et al. Remodeling of cortical bone allografts mediated by adherent rAAV-RANKL and VEGF gene therapy. Nat Med 2005; 11: 291-297.
11. Pandori M, Hobson D, Sano T. Adenovirus-microbead conjugates possess enhanced infectivity: A new strategy for localized gene delivery. Virology 2002; 299: 204-212.
12. Croyle MA, Cheng X, Wilson JM. Development of formulations that enhance physical stability of viral vectors for gene therapy. Gene Therapy 2001; 8: 1281-1290.
13. Schmitz JP, Hollinger JO. The critical size defect as an experimental model for craniomandibulofacial nonunions. Clin Orthop Relat Res 1986; 205: 299-308.
14. Friedmann T. Human gene therapy - an immature genie, but certainly out of the bottle. Nat Med 1996; 2: 144-147.
15. Franceschi RT, Wang D, Krebsbach PH, Rutherford RB. Gene therapy for bone formation: in vitro and in vivo osteogenic activity of an adenovirus expressing BMP7. J Cell Biochem 2000; 78: 476-486.
16. Schek RM, Hollister SJ, Krebsbach PH. Delivery and protection of adenoviruses using biocompatible hydrogels for localized gene therapy. Mol Ther 2004; 9: 130-138.
17. Alden TD, Pittman DD, Hankins GR, Beres EJ, Engh JA, Das S et al. In vivo endochondral bone formation using a bone morphogenetic protein 2 adenoviral vector. Hum Gene Ther 1999; 10: 2245-2253.
18. Alden TD, Beres EJ, Laurent JS, Engh JA, Das S, London SD et al. The use of bone morphogenetic protein gene therapy in craniofacial bone repair. J Craniofac Surg 2000; 11: 24-30.
19. Alden TD, Pittman DD, Beres EJ, Hankins GR, Kallmes DF, Wisotsky BM et al. Percutaneous spinal fusion using bone morphogenetic protein-2 gene therapy. J Neurosurg 1999; 90: 109-114.
20. Lindsey WH. Osseous tissue engineering with gene therapy for facial bone reconstruction. Laryngoscope 2001; 111: 1128-1136.
21. Murakami P, McCaman MT. Quantitation of adenovirus DNA and virus particles with the PicoGreen fluorescent dye. Anal Biochem 1999; 274: 283-288.
22. Okubo Y, Bessho K, Fujimura K, Iizuka T, Miyatake SI. Osteoinduction by bone morphogenetic protein-2 via adenoviral vector under transient immunosuppression. Biochem Biophys Res Commun 2000; 267: 382-387.
23. Li JZ, Hankins GR, Kao C, Li H, Kammauff J, Helm GA. Osteogenesis in rats induced by a novel recombinant helper-dependent bone morphogenetic protein-9 (BMP-9) adenovirus. J Gene Med 2003; 5: 748-756.
24. Davidson BL, Hilfinger JM, Beer SJ. Extended release of adenovirus from polymer microspheres: Potential use in gene therapy for brain tumors. Adv Drug Deliv Rev 1997; 27: 59-66.
25. Schreiber RE, Blease K, Ambrosio A, Amburn E, Sosnowski B, Sampath TK. Bone induction by AdBMP-2/collagen implants. J Bone Joint Surg Am 2005; 87: 1059-1068.
26. Tseng WC, Haselton FR, Giorgio TD. Transfection by cationic liposomes using simultaneous single cell measurements of plasmid delivery and transgene expression. J Biol Chem 1997; 272: 25641-25647.
27. Varga CM, Hong K, Lauffenburger DA. Quantitative analysis of synthetic gene delivery vector design properties. Mol Ther 2001; 4: 438-446.
28. Boontheekul T, Mooney DJ. Protein-based signaling systems in tissue engineering. Curr Opin Biotechnol 2003; 14: 559-565.
29. Vogel G. Gene therapy. FDA moves against Penn scientist. Science 2000; 290: 2049-2051.
30. Bengali Z, Shea LD. Gene delivery by immobilization to cell-adhesive substrates. Mrs Bull 2005; 30: 659-662.
31. Langer R. New methods of drug delivery. Science 1990; 249: 1527-1533.
32. Breen A, Strappe P, Kumar A, O'Brien T, Pandit A. Optimization of a fibrin scaffold for sustained release of an adenoviral gene vector. J Biomed Mater Res A 2006; 78: 702-708.
33. Bellocq NC, Kang DW, Wang X, Jensen GS, Pun SH, Schluep T et al. Synthetic biocompatible cyclodextrin-based constructs for local gene delivery to improve cutaneous wound healing. Bioconjug Chem 2004; 15: 1201-1211.
34. Bielinska AU, Yen A,Wu HL, Zahos KM, Sun R,Weiner ND et al. Application of membrane-based dendrimer/DNA complexes for solid phase transfection in vitro and in vivo. Biomaterials 2000; 21 877-887.
35. Shen H, Tan J, Saltzman WM. Surface-mediated gene transfer from nanocomposites of controlled texture. Nat Mater 2004; 3: 569-574.
36. Luo D, Saltzman WM. Enhancement of transfection by physical concentration of DNA at the cell surface. Nat Biotechnol 2000; 18: 893-895.
37. Bengali Z, Pannier AK, Segura T, Anderson BC, Jang JH, Mustoe TA et al. Gene delivery through cell culture substrate adsorbed DNA complexes. Biotechnol Bioeng 2005; 90: 290-302.
38. Gambaro K, Aberdam E, Virolle T, Aberdam D, Rouleau M. BMP-4 induces a Smad-dependent apoptotic cell death of mouse embryonic stem cell-derived neural precursors. Cell Death Differ 2006; 13: 1075-1087.
39. Wang Y, Xue SA, Hallden G, Francis J, Yuan M, Griffin BE et al. Virus-associated RNA I-deleted adenovirus, a potential oncolytic agent targeting EBV-associated tumors. Cancer Res 2005; 65: 1523-1531.
40. Pikal MJ, Dellerman K, Roy ML. Formulation and stability of freeze-dried proteins: Effects of moisture and oxygen on the stability of freeze-dried formulations of human growth hormone. Dev Biol Stand 1992; 74: 21-37; discussion 37-28.
41. Towns JK. Moisture content in proteins: Its effects and measurement. J Chromatogr A 1995; 705: 115-127.
42. Jiang S, Nail SL. Effect of process conditions on recovery of protein activity after freezing and freeze-drying. Eur J Pharm Biopharm 1998; 45: 249-257.
43. Pristoupil TI, Kramlova M, Fortova H, Ulrych S. Haemoglobin lyophilized with sucrose: The effect of residual moisture on storage. Haematologia (Budapest) 1985; 18: 45-52.
44. Yang S, Wei D, Wang D, Phimphilai M, Krebsbach PH, Franceschi RT. In vitro and in vivo synergistic interactions between the Runx2/ Cbfa1 transcription factor and bone morphogenetic protein-2 in stimulating osteoblast differentiation. J Bone Miner Res 2003; 18: 705-715.